SECONDARY ACUTE MYELOID LEUKEMIA
Clinical trials for SECONDARY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new SECONDARY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for SECONDARY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo for tough leukemia falls short in early trial
Disease control TerminatedThis study tested whether adding the drug venetoclax to standard chemotherapy could help people with a hard-to-treat type of leukemia called secondary acute myeloid leukemia (sAML). The trial aimed to enroll 20 newly diagnosed patients but was stopped early after only 10 joined. …
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Promising combo for advanced blood cancer hits snag: trial ends early
Disease control TerminatedThis study looked at combining two drugs, ruxolitinib and CPX-351, to treat advanced stages of myeloproliferative neoplasms (MPN), a group of blood cancers. The goal was to find the best dose and see if the combo worked better than standard care for patients whose disease had pro…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Experimental combo targets hard-to-treat blood cancers
Disease control TerminatedThis early-stage study tested two drugs, AZD1775 and belinostat, in 20 adults with certain blood cancers (like acute myeloid leukemia) that came back or didn't respond to prior therapy. The main goal was to find the safest dose and check side effects. The study was stopped early,…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:10 UTC